APA

Shanavas M., Messner H. A., Atenafu E. G., Kim D. H., Kuruvilla J., Lipton J. H., Uhm J., Seftel M., Alam N. & Gupta V. (20150924). Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning. : Bone marrow transplantation.

Chicago

Shanavas M, Messner H A, Atenafu E G, Kim D H, Kuruvilla J, Lipton J H, Uhm J, Seftel M, Alam N and Gupta V. 20150924. Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning. : Bone marrow transplantation.

Harvard

Shanavas M., Messner H. A., Atenafu E. G., Kim D. H., Kuruvilla J., Lipton J. H., Uhm J., Seftel M., Alam N. and Gupta V. (20150924). Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning. : Bone marrow transplantation.

MLA

Shanavas M, Messner H A, Atenafu E G, Kim D H, Kuruvilla J, Lipton J H, Uhm J, Seftel M, Alam N and Gupta V. Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning. : Bone marrow transplantation. 20150924.